MARKET

MRNA

MRNA

Moderna
NASDAQ
30.95
+0.44
+1.44%
Pre Market: 31.20 +0.25 +0.81% 08:42 12/19 EST
OPEN
30.74
PREV CLOSE
30.51
HIGH
32.21
LOW
30.61
VOLUME
21.38K
TURNOVER
--
52 WEEK HIGH
48.92
52 WEEK LOW
22.28
MARKET CAP
12.09B
P/E (TTM)
-3.8453
1D
5D
1M
3M
1Y
5Y
1D
There's No Escaping Moderna, Inc.'s (NASDAQ:MRNA) Muted Revenues Despite A 28% Share Price Rise
Simply Wall St · 4h ago
Down 80%, Should You Buy the Dip on Moderna?
The Motley Fool · 5h ago
Noteworthy Thursday Option Activity: AVGO, MRNA, IBM
NASDAQ · 20h ago
Moderna granted up to $54.3M from CEPI for bird flu vaccine
Seeking Alpha · 1d ago
CEPI to fund Phase 3 trial for Moderna’s mRNA-1018 vaccine candidate
TipRanks · 1d ago
Moderna Secures CEPI Funding for Phase 3 Trial of mRNA H5 Pandemic Flu Vaccine
Reuters · 1d ago
Moderna secures up to $54.3 million funding for bird flu vaccine from global coalition
Reuters · 1d ago
Moderna Gets $54.3M in Funding for mRNA Flu Vaccine Development
Dow Jones · 1d ago
More
About MRNA
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. The Company’s diverse development pipeline consists of 44 therapeutic and vaccine programs, 11 of which are in late-stage development. Its commercial products include Spikevax (its COVID vaccine) and mRESVIA (its respiratory syncytial virus (RSV) vaccine). Additionally, it has achieved four positive Phase III data readouts for its COVID vaccine (mRNA-1283), its RSV vaccine for high-risk adults aged 18 to 59 (mRNA-1345), its seasonal flu+COVID vaccine (mRNA-1083), and its seasonal flu vaccine (mRNA-1010).

Webull offers Moderna Inc stock information, including NASDAQ: MRNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRNA stock methods without spending real money on the virtual paper trading platform.